Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of synthetic preparation method of rivaroxaban key intermediate

A technology for rivaroxaban and intermediates, which is applied in the field of synthesis and preparation of key intermediates of rivaroxaban, can solve the problems of high cost, many side reactions and impurities, and difficulty in industrialization, and achieve low production cost, stability and High controllability and environment-friendly effect

Active Publication Date: 2019-12-24
CHANGZHOU YABANG PHARMA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] The object of the present invention is to provide a method for the synthesis and preparation of key intermediates for the synthesis of rivaroxaban, aiming to overcome the disadvantages of higher cost, more side reactions and impurities, and difficulty in industrialization in the above rivaroxaban synthesis method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic preparation method of rivaroxaban key intermediate
  • A kind of synthetic preparation method of rivaroxaban key intermediate
  • A kind of synthetic preparation method of rivaroxaban key intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Embodiment 1: the synthetic preparation of the compound shown in formula IV

[0065] The reaction formula is as follows:

[0066]

[0067] Add 500 mL of isopropanol in the reaction flask, start stirring, then add 42.0 grams (223.1 mmol) of compound shown in formula II and 87.5 grams (455.2 mmol) of compound shown in formula III, start heating, and after reflux reaction for 10 hours, Evaporate the solvent under reduced pressure, add 700 mL of dichloromethane to the residue to dissolve, then add 86.8 g (535.3 mmol) of N,N'-carbonyldiimidazole, heat to reflux for 8 hours, filter, and the filtrate with 200 mL of saturated sodium bicarbonate solution and 200 mL of saturated brine were washed once, the organic phase was dried with anhydrous sodium sulfate, filtered, and the solvent was evaporated under reduced pressure to obtain 120.2 g of the compound represented by formula IV as a light yellow solid, with a yield of 86.3%.

Embodiment 2

[0068] Embodiment 2: the synthetic preparation of the vicinal diol compound shown in formula V

[0069] The reaction formula is as follows:

[0070]

[0071] Add 300mL of 65% aqueous acetic acid solution to the reaction flask, start stirring, then add 96.0 grams (153.7mmol) of the compound shown in formula IV, react at room temperature for 2 hours, evaporate the solvent under reduced pressure, and wash the residue with 800mL dichloromethane dissolved, washed with saturated sodium bicarbonate solution (300mL×2), and washed once with 200mL saturated brine, the organic phase was dried with anhydrous sodium sulfate, filtered, and the solvent was distilled off under reduced pressure to obtain the ortho-dimethoxy compound shown in formula V The alcohol compound is 86.7 grams of off-white solid, and the yield is 96.9%.

Embodiment 3

[0072] Embodiment 3: the synthetic preparation of the aldehyde compound shown in formula VI

[0073] The reaction formula is as follows:

[0074]

[0075] In the reaction flask, add 600 mL of methanol, start stirring, add 85.0 g (145.9 mmol) of the vicinal diol compound shown in formula V, stir to dissolve, cool the reaction solution to 0°C, and add 200 mL of saturated sodium bicarbonate solution dropwise , control the temperature of the reaction solution at 0-5°C, slowly add 34.5 grams (161.3 mmol) of sodium periodate, after the addition is complete, the reaction solution is warmed up to room temperature, and the reaction is vigorously stirred for 2 hours, then anhydrous sodium sulfate is added, and after stirring for 10 minutes Filter, distill the filtrate to remove the solvent under reduced pressure, dissolve the residue completely with 600mL of dichloromethane, wash with 200mL of saturated sodium bicarbonate solution and 200mL of saturated brine each time, dry the organ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthesis preparation method of a key intermediate for synthesizing rivaroxaban as shown in formula I. The preparation method comprises the following steps: using compounds as shown in formulae II and III as the initial raw materials, performing condensation and cyclization, hydrolysis, oxidation and reductive amination to obtain the key intermediate for synthesizing rivaroxaban as shown in the formula I. The preparation method has the characteristics of being mild in reaction conditions, simple and convenient in process operation, high in stability and controllability, high in atom utilization ratio, environment-friendly, and low in production cost, is suitable for industrial mass production.

Description

technical field [0001] The invention relates to a method for synthesizing and preparing a key intermediate of rivaroxaban, and belongs to the field of pharmaceutical synthesis. Background technique [0002] Traditional anticoagulant drugs heparin and warfarin are the standard methods for the treatment and prevention of arterial and venous thrombosis, and large-scale clinical trials and clinical applications have established their status as traditional anticoagulant drugs. However, heparin is parenterally administered, with poor compliance and is not suitable for long-term use. Heparin requires antithrombin III to function, is ineffective against factor Xa in the prothrombin complex, and risks osteoporosis and potential heparin-mediated thrombocytopenia with long-term use. Warfarin has a slow onset of action, requires transition to heparin, fluctuates easily and is unpredictable in the international normalized ratio (INR), interacts with a variety of foods and drugs, has a n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D413/10C07D413/14
CPCC07D413/10C07D413/14Y02P20/55
Inventor 陈再新于水涛夏正君冯小虎林送胡超王彬王璠
Owner CHANGZHOU YABANG PHARMA